prnewswire
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
QUÉBEC, July 27, 2026 /CNW/ -- Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV:GSD) (OTCQB: DVHGF), a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announces that it is conducting an underwritten publi…